{
    "xml": "<topic id=\"PHP3816\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/saquinavir\" basename=\"saquinavir\" title=\"SAQUINAVIR\">\n<title>SAQUINAVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_791\" namespace=\"/interactions/list-of-drug-interactions/antivirals/saquinavir\">Saquinavir</xref>\n</p>\n<data name=\"vtmid\">108700005</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_643762552\" title=\"Protease inhibitors (HIV)\">Protease inhibitors (HIV)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34642\" title=\"PROTEASE INHIBITORS\" namespace=\"/drug-classes/protease-inhibitors\">PROTEASE INHIBITORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP48858\" outputclass=\"indicationsAndDose\" rev=\"1.13\" parent=\"/drugs/saquinavir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection in combination with other antiretrovirals in patients previously treated with antiretroviral therapy&#8212;with low-dose ritonavir</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g every 12&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection in combination with other antiretrovirals in patients not previously treated with antiretroviral therapy&#8212;with low-dose ritonavir</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg every 12&#8239;hours for 7 days, then increased to 1&#8239;g every 12&#8239;hours.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48913\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/saquinavir\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Bradycardia</ph>; <ph outputclass=\"contraindication\">congenital QT prolongation</ph>; <ph outputclass=\"contraindication\">electrolyte disturbances</ph>; <ph outputclass=\"contraindication\">heart failure with reduced left ventricular ejection fraction</ph>; <ph outputclass=\"contraindication\">history of symptomatic arrhythmias</ph>; <ph outputclass=\"contraindication\">predisposition to cardiac arrhythmias</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48849\" outputclass=\"interactions\" rev=\"1.9\" parent=\"/drugs/saquinavir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (saquinavir).</p>\n<p>Caution with concomitant use of garlic (avoid garlic capsules&#8212;reduces plasma-saquinavir concentration).</p>\n<p>Contra-indicated if concomitant use of drugs that prolong QT or PR interval.</p>\n<p>Contra-indicated if concomitant use of drugs that increase plasma-saquinavir concentration (avoid unless no alternative treatment available).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48797\" outputclass=\"sideEffects\" rev=\"1.12\" parent=\"/drugs/saquinavir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">changes in libido</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">increased appetite</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Convulsions</ph>; <ph outputclass=\"sideEffect\">mucosal ulceration</ph>; <ph outputclass=\"sideEffect\">renal impairment</ph>; <ph outputclass=\"sideEffect\">visual impairment</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48874\" outputclass=\"hepaticImpairment\" parent=\"/drugs/saquinavir\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in moderate impairment; avoid in decompensated liver disease.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48816\" outputclass=\"renalImpairment\" parent=\"/drugs/saquinavir\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35181\" outputclass=\"monitoringRequirements\" parent=\"/drugs/saquinavir\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor ECG before starting treatment (do not initiate treatment if QT interval over 450 milliseconds); if baseline QT interval less than 450 milliseconds, monitor ECG during treatment (particularly 10 days after starting treatment in patients not previously treated with antiretroviral therapy)&#8212;discontinue if QT interval increases over 480 milliseconds, if QT interval more than 20 milliseconds above baseline, if prolongation of PR interval, or if arrthymias occur.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48824\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/saquinavir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p outputclass=\"title\">Arrhythmias</p>\n<p>Patients should be told how to recognise signs of arrhythmia and advised to seek medical attention if symptoms such as palpitation or syncope develop.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3816-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/saquinavir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76954\" title=\"Tablet\" namespace=\"/drugs/saquinavir/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78275\" namespace=\"/treatment-summaries/hiv-infection\" title=\"HIV infection\" count=\"2\" rel=\"backlink\">HIV infection</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_791\" namespace=\"/interactions/list-of-drug-interactions/antivirals/saquinavir\" title=\"Saquinavir\" count=\"1\" rel=\"link\">Saquinavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34642\" namespace=\"/drug-classes/protease-inhibitors\" title=\"PROTEASE INHIBITORS\" count=\"1\" rel=\"link\">PROTEASE INHIBITORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76954\" namespace=\"/drugs/saquinavir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP3816",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/saquinavir",
    "basename": "saquinavir",
    "title": "SAQUINAVIR",
    "interactants": [
        {
            "id": "bnf_int_791",
            "label": "Saquinavir"
        }
    ],
    "vtmid": "108700005",
    "drugClassification": [
        "Protease inhibitors (HIV)"
    ],
    "inheritsFromClass": [
        "PROTEASE INHIBITORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "HIV infection in combination with other antiretrovirals in patients previously treated with antiretroviral therapy&#8212;with low-dose ritonavir",
                        "html": "HIV infection in combination with other antiretrovirals in patients previously treated with antiretroviral therapy&#8212;with low-dose ritonavir"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 g every 12 hours.",
                        "html": "<p>1&#8239;g every 12&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "HIV infection in combination with other antiretrovirals in patients not previously treated with antiretroviral therapy&#8212;with low-dose ritonavir",
                        "html": "HIV infection in combination with other antiretrovirals in patients not previously treated with antiretroviral therapy&#8212;with low-dose ritonavir"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "500 mg every 12 hours for 7 days, then increased to 1 g every 12 hours.",
                        "html": "<p>500&#8239;mg every 12&#8239;hours for 7 days, then increased to 1&#8239;g every 12&#8239;hours.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Bradycardia",
                "html": "Bradycardia"
            },
            {
                "type": "contraindications",
                "textContent": "congenital QT prolongation",
                "html": "congenital QT prolongation"
            },
            {
                "type": "contraindications",
                "textContent": "electrolyte disturbances",
                "html": "electrolyte disturbances"
            },
            {
                "type": "contraindications",
                "textContent": "heart failure with reduced left ventricular ejection fraction",
                "html": "heart failure with reduced left ventricular ejection fraction"
            },
            {
                "type": "contraindications",
                "textContent": "history of symptomatic arrhythmias",
                "html": "history of symptomatic arrhythmias"
            },
            {
                "type": "contraindications",
                "textContent": "predisposition to cardiac arrhythmias",
                "html": "predisposition to cardiac arrhythmias"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (saquinavir).\n\nCaution with concomitant use of garlic (avoid garlic capsules&#8212;reduces plasma-saquinavir concentration).\n\nContra-indicated if concomitant use of drugs that prolong QT or PR interval.\n\nContra-indicated if concomitant use of drugs that increase plasma-saquinavir concentration (avoid unless no alternative treatment available).",
                "html": "<p>Appendix 1 (saquinavir).</p><p>Caution with concomitant use of garlic (avoid garlic capsules&#8212;reduces plasma-saquinavir concentration).</p><p>Contra-indicated if concomitant use of drugs that prolong QT or PR interval.</p><p>Contra-indicated if concomitant use of drugs that increase plasma-saquinavir concentration (avoid unless no alternative treatment available).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "changes in libido",
                        "html": "changes in libido",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "increased appetite",
                        "html": "increased appetite",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "peripheral neuropathy",
                        "html": "peripheral neuropathy",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Convulsions",
                        "html": "Convulsions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "mucosal ulceration",
                        "html": "mucosal ulceration",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "renal impairment",
                        "html": "renal impairment",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "visual impairment",
                        "html": "visual impairment",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in moderate impairment; avoid in decompensated liver disease.",
                "html": "<p>Manufacturer advises caution in moderate impairment; avoid in decompensated liver disease.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Use with caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor ECG before starting treatment (do not initiate treatment if QT interval over 450 milliseconds); if baseline QT interval less than 450 milliseconds, monitor ECG during treatment (particularly 10 days after starting treatment in patients not previously treated with antiretroviral therapy)&#8212;discontinue if QT interval increases over 480 milliseconds, if QT interval more than 20 milliseconds above baseline, if prolongation of PR interval, or if arrthymias occur.",
                "html": "<p>Monitor ECG before starting treatment (do not initiate treatment if QT interval over 450 milliseconds); if baseline QT interval less than 450 milliseconds, monitor ECG during treatment (particularly 10 days after starting treatment in patients not previously treated with antiretroviral therapy)&#8212;discontinue if QT interval increases over 480 milliseconds, if QT interval more than 20 milliseconds above baseline, if prolongation of PR interval, or if arrthymias occur.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Arrhythmias",
                "textContent": "Patients should be told how to recognise signs of arrhythmia and advised to seek medical attention if symptoms such as palpitation or syncope develop.",
                "html": "<p>Patients should be told how to recognise signs of arrhythmia and advised to seek medical attention if symptoms such as palpitation or syncope develop.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76954",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78275",
                "label": "HIV infection",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_791",
                "label": "Saquinavir",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34642",
                "label": "PROTEASE INHIBITORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76954",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}